Cargando…
Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients nationwide before and after chemotherapy, radiation the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359663/ https://www.ncbi.nlm.nih.gov/pubmed/17565347 http://dx.doi.org/10.1038/sj.bjc.6603842 |
_version_ | 1782152887332241408 |
---|---|
author | Ryan, J L Bole, C Hickok, J T Figueroa-Moseley, C Colman, L Khanna, R C Pentland, A P Morrow, G R |
author_facet | Ryan, J L Bole, C Hickok, J T Figueroa-Moseley, C Colman, L Khanna, R C Pentland, A P Morrow, G R |
author_sort | Ryan, J L |
collection | PubMed |
description | Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients nationwide before and after chemotherapy, radiation therapy, or chemotherapy plus radiation therapy was analysed to determine if treatment type, race (Black vs White), and pretreatment expectations influenced post-treatment skin reactions. Subsequent analysis of a local Symptom Inventory completed weekly for 5 weeks by 308 patients receiving radiation therapy examined severity of reported skin reactions. Significantly more patients receiving radiation therapy had stronger expectations of skin problems (62%) than patients receiving chemotherapy (40%, P=0.001) or chemotherapy plus radiation therapy (45%, P=0.003). Overall, expectations did not correlate with patient reported post-treatment skin problems in white (r=0.014, P=0.781) or black (r=0.021, P=0.936) patients. Although no significant difference was found between black and white patients in their pretreatment expectations of skin problems (P=0.32), black patients (10 out of 18, 56%) reported more skin problems than white patients (90 out of 393, 23%, P=0.001). Similarly, the local study showed that significantly more black patients (1 out of 5, 20%) reported severe skin reactions at the treatment site than white patients (12 out of 161, 8%). A direct correlation was observed between severity of skin problems and pain at the treatment site (r=0.541, P<0.001). Total radiation exposure did not significantly correlate with the report of skin problems at the treatment site for white or black patients. Overall, black patients reported more severe post-treatment skin problems than white patients. Our results suggest that symptom management for post-treatment skin reactions in cancer patients receiving radiation treatment could differ depending on their racial background. |
format | Text |
id | pubmed-2359663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23596632009-09-10 Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations Ryan, J L Bole, C Hickok, J T Figueroa-Moseley, C Colman, L Khanna, R C Pentland, A P Morrow, G R Br J Cancer Clinical Study Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients nationwide before and after chemotherapy, radiation therapy, or chemotherapy plus radiation therapy was analysed to determine if treatment type, race (Black vs White), and pretreatment expectations influenced post-treatment skin reactions. Subsequent analysis of a local Symptom Inventory completed weekly for 5 weeks by 308 patients receiving radiation therapy examined severity of reported skin reactions. Significantly more patients receiving radiation therapy had stronger expectations of skin problems (62%) than patients receiving chemotherapy (40%, P=0.001) or chemotherapy plus radiation therapy (45%, P=0.003). Overall, expectations did not correlate with patient reported post-treatment skin problems in white (r=0.014, P=0.781) or black (r=0.021, P=0.936) patients. Although no significant difference was found between black and white patients in their pretreatment expectations of skin problems (P=0.32), black patients (10 out of 18, 56%) reported more skin problems than white patients (90 out of 393, 23%, P=0.001). Similarly, the local study showed that significantly more black patients (1 out of 5, 20%) reported severe skin reactions at the treatment site than white patients (12 out of 161, 8%). A direct correlation was observed between severity of skin problems and pain at the treatment site (r=0.541, P<0.001). Total radiation exposure did not significantly correlate with the report of skin problems at the treatment site for white or black patients. Overall, black patients reported more severe post-treatment skin problems than white patients. Our results suggest that symptom management for post-treatment skin reactions in cancer patients receiving radiation treatment could differ depending on their racial background. Nature Publishing Group 2007-07-02 2007-06-12 /pmc/articles/PMC2359663/ /pubmed/17565347 http://dx.doi.org/10.1038/sj.bjc.6603842 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Ryan, J L Bole, C Hickok, J T Figueroa-Moseley, C Colman, L Khanna, R C Pentland, A P Morrow, G R Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
title | Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
title_full | Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
title_fullStr | Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
title_full_unstemmed | Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
title_short | Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
title_sort | post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359663/ https://www.ncbi.nlm.nih.gov/pubmed/17565347 http://dx.doi.org/10.1038/sj.bjc.6603842 |
work_keys_str_mv | AT ryanjl posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT bolec posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT hickokjt posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT figueroamoseleyc posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT colmanl posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT khannarc posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT pentlandap posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations AT morrowgr posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations |